跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IXAROLA rivaroxaban 2.5 mg film-coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
IXAROLA rivaroxaban 2.5 mg film-coated tablet blister pack
Approved
STANDARD
IXAROLA rivaroxaban 2.5 mg film-coated tablet blister pack
Bayer Australia Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
d10be6e64840a138
Company
Bayer Australia Ltd
Type
Standard
Approval Details
Approval Id
d10be6e64840a138
Product Name
IXAROLA rivaroxaban 2.5 mg film-coated tablet blister pack
Artg Id
397693
Artg Name
IXAROLA rivaroxaban 2.5 mg film-coated tablet blister pack
Sponsor
Bayer Australia Ltd
Company Detail Path
/organization/bayer-australia-ltd
Artg Date
2023-02-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/202308bc858d610905fb6961837c1281.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/636966799a6a911710b477bf9360ba87.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
d10be6e64840a138
Type
Standard
Back to TGA Approvals